Are biostimulators and skin boosters the same?
They overlap as treatment descriptions, but they are not interchangeable categories. Sculptra contains PLLA, standard Juvelook combines PDLLA with hyaluronic acid (HA), and Radiesse contains calcium hydroxylapatite (CaHA). These collagen-stimulating materials differ from Rejuran’s polynucleotide (PN) formulation and Skinvive’s HA gel. “Skin booster” is a broad description of treatments intended to improve skin quality, not one ingredient or a guarantee of the same results.
Some collagen stimulators are also classified as fillers. The useful distinction is the exact formulation and intended use, rather than “filler versus natural collagen” or country of origin. Our guide to hyaluronic acid explains how HA skincare and injectable gels differ.
If smoothness or hydration is your main concern, the skin-booster comparison covers those product choices. Having both skin-quality concerns and laxity does not automatically mean you need both treatment categories.
Biostimulators and skin-quality injectables compared
Use this table to identify the question each product needs to answer. It is not a league table: the studies involve different people, treatment areas and outcomes.
| Product and material | Goal to clarify | Early effect | Comparison and correction limits |
|---|---|---|---|
| Sculptra / PLLA | Gradual changes in specified facial wrinkles and tissue response | Changes develop over time; early fullness is not the final result | Not an instant final contour correction; PLLA does not dissolve with hyaluronidase like HA |
| Radiesse / CaHA; (+) contains lidocaine | Contour or volume support, distinguished from skin-quality treatment | Can provide initial volume correction when used for filling, with later changes | Exact version and indication matter; CaHA does not dissolve with hyaluronidase like HA |
| Standard Juvelook / PDLLA + HA | Wrinkle and skin-quality questions supported by the exact formulation’s evidence | Immediate fullness should not be read as newly formed collagen | Cited evidence is small and includes added HA; dissolving HA does not dissolve PDLLA |
| Rejuran PN formulation / polynucleotide | Wrinkles and skin quality in studied areas | The cited evidence does not establish a universal onset timetable | Not PLLA, CaHA or HA; does not establish treatment of skin disease or general cell repair |
| Skinvive / cross-linked HA + lidocaine | Cheek smoothness and neck lines under its U.S. label | Assess the intended skin outcome rather than assuming structural contouring | Different aim from PLLA/PDLLA; dissolvable HA does not mean every complication can be reversed |
Product names and local labels matter more than marketing categories. These overseas descriptions do not confirm Thai authorisation or the availability of every formulation at the clinic.
Sculptra: understanding gradual PLLA-related changes
Sculptra contains poly-L-lactic acid (PLLA). Its U.S. label covers specified facial folds and wrinkles, including cheek wrinkles. This is a reason to match the proposed treatment to a particular concern, rather than treating “collagen stimulation” as a promise to lift every kind of loose skin.
Fullness immediately after treatment can partly reflect swelling. A day-one photograph therefore cannot show the final collagen-related result. A reduction in that early fullness does not, by itself, mean the treatment has failed or that another session is needed immediately.
A useful consultation question is: “What will we compare at review, and when can we judge whether further treatment is appropriate?” The Sculptra guide covers product-specific details.
Radiesse and Radiesse (+): early volume and contour goals
When comparing Sculptra with Radiesse, the practical difference is what you expect first. Radiesse’s CaHA-in-gel formulation can provide initial volume correction when used for filling, alongside later collagen stimulation. Sculptra-related changes develop gradually. Early fullness is not evidence of instant new collagen or the final result.
Radiesse (+) Lidocaine contains lidocaine. Its U.S. label also includes improving moderate to severe loss of jawline contour in adults over 21. That indication should not be transferred to every Radiesse version or assumed to apply in Thailand. If treatment is proposed for skin quality, ask how that aim differs from structural filling.
The cited labels are not a direct comparison of Sculptra and Radiesse. They cannot establish which lifts more, lasts longer or is safer. The Radiesse Plus guide provides formulation-specific information.
HArmonyCa is a different combined product. It contains HA, CaHA and lidocaine, rather than being another name for Radiesse. Its HA component does not make the CaHA component dissolvable with hyaluronidase. See the separate HArmonyCa guide.
Juvelook: why the exact formulation matters
Standard Juvelook combines PDLLA with HA. PDLLA is not Sculptra’s PLLA, and sharing a broad collagen-stimulator description does not make the products or their evidence interchangeable.
The cited Juvelook study was small, uncontrolled and short-term; it also used additional HA. Its findings cannot be assigned to Juvelook alone or transferred to Juvelook Volume and every other version of the brand.
If the proposal is for skin quality, ask for the full product name and the specific outcome being targeted: texture, wrinkles or volume. Results from other treatments performed alongside it should not be presented as evidence for one injectable alone.
Rejuran and Skinvive: comparing skin-quality goals
Rejuran’s PN formulation contains polynucleotide. The manufacturer describes temporary improvement of facial wrinkles, and small studies examine skin quality in particular areas. These findings do not establish a treatment for sensitive skin, skin disease or general “cell repair”. Active irritation or a rash needs to be distinguished from an aesthetic skin-quality concern.
Skinvive by Juvéderm is cross-linked HA with lidocaine. Its U.S. label covers cheek smoothness and reducing neck lines in adults over 21. These goals differ from filling a deep hollow or changing facial structure; the presence of HA does not make every HA product suitable for the same task.
Compare what you want to change with what the research actually measured, rather than relying on descriptions such as “regenerative” or “glowing”. Our HA guide distinguishes topical skincare from injectable gels.
Hollowing, laxity or dryness: start with the concern
“Looking tired” can describe several different problems. Naming the change you want makes it easier to compare options than starting with a brand.
| Concern | What needs distinguishing | Useful decision question |
|---|---|---|
| Hollows or deeper folds | Lost volume versus shadows from laxity or facial structure | Do you want a defined contour correction or a gradual change, and which is appropriate for the actual concern? |
| Loose skin or a less defined jawline | Laxity versus local volume and shape | Would adding volume help, risk unwanted fullness, or leave the main problem unchanged? |
| Dry, flaky or stinging skin | Ordinary dryness versus irritation or skin disease | Would barrier care or treating the cause be a better first step than an injection? |
| Uneven texture or fine lines | Surface appearance versus a deeper fold or volume deficit | Did the product study measure the outcome and treatment area that matter to you? |
Having both hollowing and laxity does not automatically justify a combination package. Establish the main concern, then consider whether addressing it changes the need for another treatment. Evaluating one goal at a time can also help distinguish which intervention produced which change; it does not impose one treatment sequence on everyone.
If adding volume or reshaping is the main aim, our HA filler comparison covers another set of choices. If the goal is still unclear, assessment or observation without an injection is a valid next step. You do not need to choose a product at the first visit.
Onset, assessment, duration and sessions are different questions
Early fullness, a later treatment result and the length of a research follow-up describe different things. A two-year study does not mean everyone gets two years from one session or should automatically repeat treatment at that point.
What might you notice first?
Distinguish early filling effects from swelling and gradual tissue changes. With Sculptra, a first-day photo cannot establish the collagen-related outcome. With Radiesse used for filling, early volume correction does not mean every treatment effect is complete.
When is the outcome assessed, and how long might it last?
Agree on a review point that matches the formulation, treatment area and outcome being measured. Sculptra’s U.S. cheek-wrinkle study followed improvement through 24 months after initial treatment, with up to four sessions. That is not a two-year guarantee from one injection. Skinvive’s cheek study assessed improvement through six months after initial treatment or an optional touch-up; it does not establish the same duration for other products or treatment areas.
The smaller Juvelook and Rejuran studies cited here do not establish a universal onset or maintenance schedule. The Juvelook study also used additional HA, so its results cannot be attributed to Juvelook alone. The evidence used in this comparison cannot rank the brands by longest-lasting result.
How many sessions will you need?
A study protocol or package size is not a prescription for every patient. Ask which sessions are an estimate and what would justify additional treatment after assessment. Early fullness fading or a package discount alone should not decide whether to repeat an injection.
For someone living between Thailand and another country, this also means planning who will review progress if the response develops after departure. Do not compress the assessment process to fit a short visit.
How to compare the cost of a treatment plan
Cost per vial, syringe or cc is not a direct comparison of value across different formulations. Ask for an itemised quote that makes these points clear:
- The exact product and version, quantity and unit.
- The treatment area and goal covered by that price.
- Whether the quote is for one session or a plan, and which future sessions are estimates.
- What assessment, follow-up and other fees are included or excluded.
- What happens if treatment is postponed or reassessment means fewer sessions are needed.
Compare the proposed outcome and total commitment, not just the price of one container. Published prices do not replace a current written quote for your proposed plan.
Where to check current clinic prices
See the current Smooth Clinic price page for the latest published listings, checked on 17 October 2026. Confirm the exact product, version, quantity, unit and total cost with the clinic before booking. Prices and package conditions can change; the itemised checklist above helps you compare what is actually included.
What risks and correction limits matter?
Injections can cause pain, swelling, bruising, redness or infection. Persistent lumps, delayed inflammation and allergic reactions are possible. There is no guarantee of no downtime or a complication-free result.
Accidental injection into a blood vessel can damage tissue and cause blindness or stroke. Severe or unusual pain, pale skin or dusky, mottled discolouration needs immediate medical assessment. If the treating doctor cannot assess you immediately, go to an emergency department. Vision changes, weakness, facial drooping, difficulty speaking, breathing difficulty, tongue or throat swelling, or collapse require emergency hospital care immediately. Do not wait for a routine review.
Hyaluronidase can break down HA, but it does not remove PLLA, PDLLA, CaHA or PN in the same way. Having HA in a combination product does not make every ingredient dissolvable. Dissolving HA filler has limits and risks; it cannot guarantee reversal of every complication or restoration of lost vision.
What should you check before and after treatment in Thailand?
- Postpone treatment in an inflamed or infected area until the cause is assessed and controlled. Sensitive skin does not automatically make a product suitable.
- Discuss medical history: severe allergies, ingredient or lidocaine allergy, raised scars, bleeding problems, immune conditions, medicines, supplements and previous procedures matter. Sculptra is contraindicated with a history of keloids or hypertrophic scarring. Pregnancy or breastfeeding warrants discussing postponement of elective treatment. Radiesse and Radiesse (+) are contraindicated in patients with bleeding disorders under their U.S. labels. Do not stop prescribed medicines yourself.
- Check the product and provider: use a licensed clinic and doctor. Confirm the exact product, current Thai authorisation, labelled importer, lot number and expiry date, and ask about emergency referral arrangements.
- Follow product-specific aftercare: massage, exercise and skincare advice can differ. Do not apply one brand’s instructions to another. Increasing redness, warmth, pain, fever or unusual lumps needs prompt review.
For treatment in Thailand, review the biostimulator service overview and ask for an assessment, an itemised quote and follow-up arrangements you understand. If you may leave Thailand before review, ask who will assess a delayed problem and request the product name, lot and treatment record to share with your next clinician. Confirm language support before booking.
Frequently asked questions before choosing a biostimulator
Can a biostimulator replace HA filler?
Some collagen stimulators are also fillers, but they are not universal substitutes. For a particular hollow or contour, the formulation, expected effect and evidence for that area matter. “Stimulates collagen” does not establish the same result as a specific HA filler.
Do I need a skin booster as well?
Not automatically. A single main concern can be assessed on its own. If several treatments are proposed, each should have a clear additional purpose and an explanation of the extra risk, cost and follow-up involved.
What if being able to reverse the result matters to me?
Discuss this before choosing a material. PLLA and CaHA do not dissolve with hyaluronidase in the way HA does. Even HA treatment does not guarantee that every unwanted result or complication can be reversed. Biodegradable over time does not mean immediately removable.
Can all these products be used under the eyes?
No. Sculptra’s U.S. label states that peri-orbital use has not been studied and notes reports of increased papules and nodules in this area; the cited Radiesse labels do not establish safety and effectiveness there. A PN study in one area does not establish that every material or formulation is suitable under the eyes.
Does overseas approval establish the same authorised use in Thailand?
No. The exact product, version and relevant Thai indication need separate checking. A brand name or registration number alone does not explain whether the proposed use matches its local label or what limitations apply.
What should I bring if I previously had injections abroad?
Bring the product name and version, treatment date, area, recorded quantity and unit, and any details of previous reactions. If the material is unknown, say so rather than guessing from how long it lasted or how your face looks. Ask for a treatment record after any new procedure so your next clinician has the same information.
What should be clear before you decide?
You should understand the main concern, why a particular formulation is proposed, how and when results will be assessed, the total cost and who to contact if something is wrong. A claim that one brand is “best” without that explanation leaves important questions unanswered.
References
- Galderma. Sculptra U.S. instructions for use, including cheek-wrinkle study follow-up.
- VAIM. Juvelook formulation and product range.
- Seo SB, et al. Preliminary study of PDLLA combined with additional HA. Journal of Cosmetic Dermatology. 2024;23:794–802.
- PharmaResearch. Rejuran PN product information.
- Lee YJ, et al. Randomised split-face study of PN and HA for periocular rejuvenation. Journal of Dermatological Treatment. 2022;33:254–260.
- AbbVie. Skinvive by Juvéderm U.S. directions for use. U.S. FDA. Neck-indication approval, 11 June 2026.
- U.S. FDA. Dermal filler risks and patient information; 2025 advisory-panel summary, pages 16–17, on removal limitations.
- Merz. Radiesse U.S. instructions for use; Radiesse (+) Lidocaine U.S. instructions for use; manufacturer explanation of early volume and collagen stimulation.
- Allergan Aesthetics Australia. HArmonyCa Lidocaine instructions for use. Manufacturer product information. Overseas labels do not establish Thai authorisation.